126 related articles for article (PubMed ID: 20690072)
1. Long-term but not short-term aspirin treatment attenuates diabetes-associated learning and memory decline in mice.
Wang T; Fu FH; Han B; Zhang LM; Zhang XM
Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):36-40. PubMed ID: 20690072
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Re attenuates diabetes-associated cognitive deficits in rats.
Liu YW; Zhu X; Li W; Lu Q; Wang JY; Wei YQ; Yin XX
Pharmacol Biochem Behav; 2012 Mar; 101(1):93-8. PubMed ID: 22197711
[TBL] [Abstract][Full Text] [Related]
3. Lycopene attenuates diabetes-associated cognitive decline in rats.
Kuhad A; Sethi R; Chopra K
Life Sci; 2008 Jul; 83(3-4):128-34. PubMed ID: 18585396
[TBL] [Abstract][Full Text] [Related]
4. Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats: involvement of amyloid-beta decrease in brain.
Liu YW; Zhu X; Lu Q; Wang JY; Li W; Wei YQ; Yin XX
J Ethnopharmacol; 2012 Jan; 139(1):194-200. PubMed ID: 22101084
[TBL] [Abstract][Full Text] [Related]
5. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats.
Lupien SB; Bluhm EJ; Ishii DN
J Neurosci Res; 2003 Nov; 74(4):512-23. PubMed ID: 14598295
[TBL] [Abstract][Full Text] [Related]
6. Timosaponin AIII, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in mice.
Lee B; Jung K; Kim DH
Pharmacol Biochem Behav; 2009 Aug; 93(2):121-7. PubMed ID: 19426756
[TBL] [Abstract][Full Text] [Related]
7. Modulation of neuro-inflammatory condition, acetylcholinesterase and antioxidant levels by genistein attenuates diabetes associated cognitive decline in mice.
Rajput MS; Sarkar PD
Chem Biol Interact; 2017 Apr; 268():93-102. PubMed ID: 28259689
[TBL] [Abstract][Full Text] [Related]
8. Suppression of neuro-inflammatory signaling cascade by tocotrienol can prevent chronic alcohol-induced cognitive dysfunction in rats.
Tiwari V; Kuhad A; Chopra K
Behav Brain Res; 2009 Nov; 203(2):296-303. PubMed ID: 19464322
[TBL] [Abstract][Full Text] [Related]
9. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences.
Kuhad A; Chopra K
Eur J Pharmacol; 2007 Dec; 576(1-3):34-42. PubMed ID: 17822693
[TBL] [Abstract][Full Text] [Related]
10. Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats.
Bhutada P; Mundhada Y; Bansod K; Bhutada C; Tawari S; Dixit P; Mundhada D
Neurobiol Learn Mem; 2010 Oct; 94(3):293-302. PubMed ID: 20620214
[TBL] [Abstract][Full Text] [Related]
11. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
Abdin AA; Baalash AA; Hamooda HE
J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
[TBL] [Abstract][Full Text] [Related]
12. Puerarin ameliorates cognitive deficits in streptozotocin-induced diabetic rats.
Liu X; Mo Y; Gong J; Li Z; Peng H; Chen J; Wang Q; Ke Z; Xie J
Metab Brain Dis; 2016 Apr; 31(2):417-23. PubMed ID: 26686502
[TBL] [Abstract][Full Text] [Related]
13. Minocycline improves postoperative cognitive impairment in aged mice by inhibiting astrocytic activation.
Jin WJ; Feng SW; Feng Z; Lu SM; Qi T; Qian YN
Neuroreport; 2014 Jan; 25(1):1-6. PubMed ID: 24247278
[TBL] [Abstract][Full Text] [Related]
14. Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits.
Kuhad A; Bishnoi M; Tiwari V; Chopra K
Pharmacol Biochem Behav; 2009 Apr; 92(2):251-9. PubMed ID: 19138703
[TBL] [Abstract][Full Text] [Related]
15. Oxymatrine attenuates diabetes-associated cognitive deficits in rats.
Wang SB; Jia JP
Acta Pharmacol Sin; 2014 Mar; 35(3):331-8. PubMed ID: 24442148
[TBL] [Abstract][Full Text] [Related]
16. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
17. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes.
Alvarez EO; Beauquis J; Revsin Y; Banzan AM; Roig P; De Nicola AF; Saravia F
Behav Brain Res; 2009 Mar; 198(1):224-30. PubMed ID: 19041902
[TBL] [Abstract][Full Text] [Related]
18. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
Brzozowska I; Targosz A; Sliwowski Z; Kwiecien S; Drozdowicz D; Pajdo R; Konturek PC; Brzozowski T; Pawlik M; Konturek SJ; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
[TBL] [Abstract][Full Text] [Related]
19. Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis.
Davari S; Talaei SA; Alaei H; Salami M
Neuroscience; 2013 Jun; 240():287-96. PubMed ID: 23500100
[TBL] [Abstract][Full Text] [Related]
20. Intrahippocampal administration of A beta(1-40) impairs spatial learning and memory in hyperglycemic mice.
Huang HJ; Liang KC; Chen CP; Chen CM; Hsieh-Li HM
Neurobiol Learn Mem; 2007 May; 87(4):483-94. PubMed ID: 17241793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
